Detection and evaluation of the role of sarcopenia in elderly patients with cancer treated with chemotherapy. ONCOSARCO project;Detección y evaluación del papel de la sarcopenia en ancianos con cáncer tratados con quimioterapia. Proyecto ONCOSARCO

Revista Espanola de Geriatria y Gerontologia

Volumn 52, Issue 3, 2017, Pages 146-151

  Molina Garrido, Maria José ^a   Guillén Ponce, Carmen ^b   Fernández Félix, Borja Manuel ^b   Muñoz Sánchez, Maria del Mar ^a   Soriano Rodríguez, Maria del Carmen ^a   Olaverri Hernández, Amaya ^a   Santiago Crespo, Jose Antonio ^a  

^a HOSPITAL VIRGEN DE LA LUZ   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Cancer; Chemotherapy; Elderly; Frailty; Sarcopenia

Indexed keywords

ANTINEOPLASTIC AGENT;

AGED; ARTICLE; CONTROLLED STUDY; FRAILTY; GRIP STRENGTH; HUMAN; MALIGNANT NEOPLASM; MUSCLE MASS; OBSERVATIONAL STUDY; PINCH STRENGTH; PREDICTION; PROSPECTIVE STUDY; SARCOPENIA; SPAIN; WALKING SPEED; COMPLICATION; FEMALE; GERIATRIC ASSESSMENT; LONGITUDINAL STUDY; MALE; NEOPLASM;

AGED; ANTINEOPLASTIC AGENTS; FEMALE; GERIATRIC ASSESSMENT; HUMANS; LONGITUDINAL STUDIES; MALE; NEOPLASMS; PROSPECTIVE STUDIES; SARCOPENIA;

EID: 84962179514     PISSN: 0211139X     EISSN: 15781747     Source Type: Journal    
DOI: 10.1016/j.regg.2016.02.003     Document Type: Article

References (35)

1. Cassel, C.K., Use it or lose it: activity may be the best treatment for aging. JAMA. 288 (2002), 2333–2335.
2. Morley, J.E., The top 10 hot topics in aging. J Gerontol A Biol Sci Med Sci. 59 (2004), 24–33.
3. Ferrucci, L., Guralnik, J.M., Studenski, S., Fried, L.P., Cutler, G.B.,J.R., Walston, J.D., Designing randomized, controlled trials aimed at preventing or delaying functional decline and disability in frail, older persons: a consensus report. J Am Geriatr Soc. 52 (2004), 625–634.
4. Bortz, W.M., A conceptual framework of frailty: a review. J Gerontol A Biol Sci Med Sci. 57 (2002), 283–288.
5. Rockwood, K., Hogan, D.B., Macknight, C., Conceptualisation and measurement of frailty in elderly people. Drugs Aging. 17 (2000), 295–302.
6. Morley, J.E., Mobility performance: a hightech test for geriatricians. J Gerontol A Biol Sci Med Sci. 58 (2003), 712–714.
7. Buchner, D.M., Wagner, E.H., Preventing frail health. Clin Geriatr Med. 8 (1992), 1–17.
8. Fried, L.P., Tangen, C.M., Walston, C.M., Walston, J., Newman, A.B., Hirsch, C., et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 56 (2001), 146–156.
9. Rosenberg, I.H., Roubenoff, R., Stalking sarcopenia. Ann Intern Med. 123 (1995), 727–728.
10. Cawthon, P.M., Marshall, L.M., Michael, Y., Dam, T.T., Ensrud, K.E., Barrett-Connor, E., et al. Frailty in older men: prevalence, progression, and relationship with mortality. J Am Geriatr Soc. 55 (2007), 1216–1223.
11. Iannuzzi-Suchich, M., Prestwood, K.M., Kenny, A.M., Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women. J Gerontol A Biol Sci Med Sci. 57 (2002), M772–M777.
12. Newman, A.B., Kupelian, V., Visser, M., Simonsick, E., Goodpaster, B., Nevitt, M., et al. Sarcopenia: alternative definitions and associations with lower extremity function. J Am Geriatr Soc. 51 (2003), 1602–1609.
13. Cruz-Jentoft, A.J., Baeyens, J.P., Bauer, J.M., Boirie, Y., Cederholm, T., Landi, F., et al., European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 39 (2010), 412–423.
14. Prado, C.M., Lieffers, J.R., McCargar, L.J., Reiman, T., Sawyer, M.B., Martin, L., et al. Prevalence and clinical implications of sarcopenia obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 9 (2008), 629–635.
15. Prado, C.M., Baracos, V.E., McCargar, L.J., Reiman, T., Mourtzakis, M., Tonkin, K., et al. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res. 15 (2009), 2920–2926.
16. Awad, S., Tan, B.H., Cui, H., Bhalla, A., Fearon, K.C., Parsons, S.L., et al. Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer. Clin Nutr. 31 (2012), 74–77.
17. Mir, O., Coriat, R., Blanchet, B., Durand, J.P., Blanchet, B., Durand, J.P., et al. Sarcopenia predicts early dose-limiting toxicities and pharmacokinetics of sorafenib in patients with hepatocellular carcinoma. PLoS ONE., 7, 2012, e37563.
18. Lieffers, J.R., Bathe, O.F., Fassbender, K., Winget, M., Baracos, V.E., Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer. 107 (2012), 931–936.
19. Veasey-Rodrigues, H., Parsons, H.A., Janku, F., Naing, A., Wheler, J.J., Tsimberidou, A.M., et al. A pilot study of temsirolimus and body composition. J Cachexia Sarcopenia Muscle. 4 (2013), 259–265.
20. Harimoto, N., Shirabe, K., Yamashita, Y.I., Ikegami, T., Yoshizumi, T., Soejima, Y., et al. Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma. Br J Surg. 100 (2013), 1523–1530.
21. Pemberton, L., Sumra, P., Tetlow, C., Bayman, N., Summers, Y., Taylor, P., et al. Do treatment decisions made at lung cancer multi-disciplinary team meetings (MDTs) reflect the actual treatment given in practice?. Lung Cancer., 79, 2013, S36.
22. Jannsen, I., Heymsfield, S.B., Baumgartner, R.N., Ross, R., Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol 89 (2000), 465–471.
23. Moreira, D., Aiza, R., de Gogoy, J.R., do Nascimento, A., Approach about palmar prehension using dynamometer JAMAR: a literature revision. R Bras Ci e Mov Brasilia 11 (2003), 95–99.
24. Abizanda, P., Navarro, J.L., García-Tomás, M.I., López-Jiménez, E., Martínez-Sánchez, E., Paterna, G., Validity and usefulness of hand-held dynamometry for measuring muscle strength in community-dwelling older persons. Arch Gerontol Geriatr. 54 (2012), 21–27.
25. Montero-Odasso, M., Schapira, M., Soriano, E.R., Valera, M., Kaplan, R., Camera, L.A., et al. Gain velocity as a single predictor of adverse events in healthy seniors aged 75 years and older. J Gerontol A Biol Sci Med Sci. 60 (2005), 1304–1309.
26. Perera, S., Studenski, S., Chandler, J.M., Guralnick, J.M., Magnitude and patterns of decline in health and function in 1 year affect subsequent 5 year survival. J Gerontol A Biol Sci Med Sci. 60 (2005), 894–900.
27. Cesari, M., Kritchevsky, S.B., Penninx, B.W., Nicklas, B.J., Simonsick, E.M., Newman, A.B., et al. Prognostic value of usual gait speed in well-functioning older people-results from the Health, Aging and Body Composition Study. J Am Geriatr Soc. 53 (2005), 1675–1680.
28. Sudenski, S., Perera, S., Wallace, D., Chandler, J.M., Duncan, P.W., Rooney, E., Physical performance measures in the clinical setting. J Am Geriatr Soc. 51 (2003), 314–322.
29. Guralnik, J.M., Simonsick, E.M., Ferrucci, L., Glynn, R.J., Berkman, L.F., Blazer, D.J., et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 49 (1994), M85–M94.
30. World Medical Association Declaration of Helsinki. 58th WMA General Assembly, Seoul. October 2008 [consultado 3 Nov 2012]. Disponible en: http://www.wma.net/e/policy/b3.htm.
31. Laurentani, F., Russo, C., Bandinelli, S., Bartali, B., Cavazzini, C., Di Lorio, A., et al. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol. 95 (2003), 1851–1860.
32. Chien, M.Y., Huang, T.Y., Wu, Y.T., Prevalence of sarcopenia estimated using a bioelectrical impedance analysis prediction equation in community-dwelling elderly people in Taiwan. J Am Geriatr Soc. 56 (2008), 1710–1715.
33. Escalona, P., Naranjo, J., Lagos, V., Solís, F., Parámetros de normalidad en fuerzas de prensión de mano en sujetos de ambos sexos de 7 a 17 años de edad. Rev Chil Pediatr. 80 (2009), 435–443.
34. Li, D., de Glas, N.A., Hurria, A., Cancer and aging: General principles, biology, and geriatric assessment. Clin Geriatr Med. 32 (2016), 1–15.
35. Talarico, L., Chen, G., Pazdur, R., Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration. J Clin Oncol. 22 (2004), 4626–4631.